Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments: 2012-2020

Historic Change in Acquisitions & Divestments for Cumberland Pharmaceuticals (CPIX) over the last 8 years, with Dec 2020 value amounting to -$460,888.

  • Cumberland Pharmaceuticals' Change in Acquisitions & Divestments fell 110.53% to -$460,888 in Q4 2020 from the same period last year, while for Dec 2020 it was $11.5 million, marking a year-over-year decrease of 42.69%. This contributed to the annual value of $20.1 million for FY2019, which is 24.44% up from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Change in Acquisitions & Divestments of -$460,888 as of Q4 2020, which was down 200.00% from $460,888 recorded in Q3 2020.
  • Cumberland Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $9.2 million for Q3 2018, and its period low was -$460,888 during Q4 2020.
  • Its 3-year average for Change in Acquisitions & Divestments is $4.0 million, with a median of $4.3 million in 2018.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Change in Acquisitions & Divestments surged by 972.73% in 2017, and later slumped by 110.53% in 2020.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Change in Acquisitions & Divestments stood at $812,366 in 2016, then skyrocketed by 359.95% to $3.7 million in 2017, then increased by 28.78% to $9.2 million in 2018, then decreased by 22.74% to $4.4 million in 2019, then slumped by 110.53% to -$460,888 in 2020.
  • Its last three reported values are -$460,888 in Q4 2020, $460,888 for Q3 2020, and $4.4 million during Q4 2019.